GlaxoSmithKline PLC (GSK) — Capital Reinvestment Ratio
Latest as of September 2025:
0.40x
GlaxoSmithKline PLC (GSK) has a Capital Reinvestment Ratio of 0.40x as of September 2025, meaning it reinvests 0% of its operating cash flow (GBX2.22 Billion) in capital expenditures (GBX879.00 Million). See GlaxoSmithKline PLC free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.40x
Capex / Operating Cash Flow
Operating Cash Flow
GBX2.22 Billion
GBX
Capital Expenditures
GBX879.00 Million
GBX
Data as of
Sep 2025
Most recent filing
GlaxoSmithKline PLC Capital Reinvestment Ratio (1990–2024)
This chart tracks GlaxoSmithKline PLC's Capital Reinvestment Ratio across 40 annual periods.
Annual Capital Reinvestment Ratio for GlaxoSmithKline PLC (1990–2024)
Year-by-year Capital Reinvestment Ratio for GlaxoSmithKline PLC from 1990 to 2024. For live market cap and broader valuation context, see market value of GlaxoSmithKline PLC.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.45x | GBX6.55 Billion | GBX2.98 Billion | ▲ +31.4% |
| 2023 | 0.35x | GBX6.77 Billion | GBX2.34 Billion | ▲ +13.5% |
| 2022 | 0.31x | GBX7.40 Billion | GBX2.26 Billion | ▼ -17.2% |
| 2021 | 0.37x | GBX7.95 Billion | GBX2.93 Billion | ▲ +39.0% |
| 2020 | 0.27x | GBX8.44 Billion | GBX2.24 Billion | ▼ -1.6% |
| 2019 | 0.27x | GBX8.02 Billion | GBX2.16 Billion | ▲ +26.5% |
| 2018 | 0.21x | GBX8.42 Billion | GBX1.80 Billion | ▼ -33.0% |
| 2017 | 0.32x | GBX6.92 Billion | GBX2.20 Billion | ▼ -12.1% |
| 2016 | 0.36x | GBX6.50 Billion | GBX2.35 Billion | ▼ -51.1% |
| 2015 | 0.74x | GBX2.57 Billion | GBX1.90 Billion | ▲ +118.7% |
| 2014 | 0.34x | GBX5.18 Billion | GBX1.75 Billion | ▲ +43.6% |
| 2013 | 0.24x | GBX7.22 Billion | GBX1.70 Billion | ▼ -32.2% |
| 2012 | 0.35x | GBX4.38 Billion | GBX1.52 Billion | ▲ +63.5% |
| 2011 | 0.21x | GBX6.25 Billion | GBX1.33 Billion | ▼ -11.7% |
| 2010 | 0.24x | GBX6.80 Billion | GBX1.64 Billion | ▲ +0.7% |
| 2009 | 0.24x | GBX7.84 Billion | GBX1.87 Billion | ▼ -15.6% |
| 2008 | 0.28x | GBX7.31 Billion | GBX2.07 Billion | ▼ -23.5% |
| 2007 | 0.37x | GBX5.79 Billion | GBX2.14 Billion | ▼ -7.9% |
| 2006 | 0.40x | GBX3.96 Billion | GBX1.59 Billion | ▲ +90.0% |
| 2005 | 0.21x | GBX5.59 Billion | GBX1.18 Billion | ▲ +295.2% |
| 2004 | 0.05x | GBX4.77 Billion | GBX255.00 Million | ▼ -75.6% |
| 2003 | 0.22x | GBX4.85 Billion | GBX1.06 Billion | ▼ -45.4% |
| 2002 | 0.40x | GBX3.06 Billion | GBX1.23 Billion | ▲ +65.4% |
| 2001 | 0.24x | GBX4.61 Billion | GBX1.12 Billion | ▼ -59.3% |
| 2000 | 0.60x | GBX1.85 Billion | GBX1.10 Billion | ▼ -49.1% |
| 1999 | 1.17x | GBX510.00 Million | GBX597.00 Million | ▲ +1.0% |
| 1998 | 1.16x | GBX410.00 Million | GBX475.00 Million | ▲ +71.7% |
| 1997 | 0.67x | GBX615.00 Million | GBX415.00 Million | ▲ +42.9% |
| 1996 | 0.47x | GBX849.00 Million | GBX401.00 Million | ▼ -13.5% |
| 1995 | 0.55x | GBX1.25 Billion | GBX684.00 Million | ▲ +175.5% |
| 1995 | 0.20x | GBX2.45 Billion | GBX485.59 Million | ▲ +0.0% |
| 1994 | 0.20x | GBX2.45 Billion | GBX485.59 Million | ▼ -63.7% |
| 1994 | 0.55x | GBX1.05 Billion | GBX575.00 Million | ▲ +0.0% |
| 1993 | 0.55x | GBX1.05 Billion | GBX575.00 Million | ▼ -16.7% |
| 1993 | 0.66x | GBX927.00 Million | GBX608.00 Million | ▲ +0.0% |
| 1992 | 0.66x | GBX927.00 Million | GBX608.00 Million | ▼ -27.5% |
| 1992 | 0.90x | GBX657.00 Million | GBX594.00 Million | ▲ +0.0% |
| 1991 | 0.90x | GBX657.00 Million | GBX594.00 Million | ▼ -8.2% |
| 1991 | 0.99x | GBX615.00 Million | GBX606.00 Million | ▲ +0.0% |
| 1990 | 0.99x | GBX615.00 Million | GBX606.00 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow